Details for New Drug Application (NDA): 075340
✉ Email this page to a colleague
NDA 075340 describes HYDROXYUREA, which is a drug marketed by Barr, Barr Labs Inc, Endo Operations, Leading, Qilu, and Roxane, and is included in seven NDAs. It is available from twelve suppliers. Additional details are available on the HYDROXYUREA profile page.
The generic ingredient in HYDROXYUREA is hydroxyurea. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
The generic ingredient in HYDROXYUREA is hydroxyurea. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
Summary for 075340
| Tradename: | HYDROXYUREA |
| Applicant: | Endo Operations |
| Ingredient: | hydroxyurea |
| Patents: | 0 |
Suppliers and Packaging for NDA: 075340
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HYDROXYUREA | hydroxyurea | CAPSULE;ORAL | 075340 | ANDA | Major Pharmaceuticals | 0904-6939 | 0904-6939-61 | 100 BLISTER PACK in 1 CARTON (0904-6939-61) / 1 CAPSULE in 1 BLISTER PACK |
| HYDROXYUREA | hydroxyurea | CAPSULE;ORAL | 075340 | ANDA | Endo USA, Inc. | 49884-724 | 49884-724-01 | 100 CAPSULE in 1 BOTTLE (49884-724-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Feb 24, 1999 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
